Opinion: A single-dose HPV vaccine would have a big impact on cancer prevention
As the father of three teenagers, as a son whose father lost his battle with…
Category: Biotech
Here are the contenders for STAT Madness 2020. Voting begins March 2
A DNA microscope. A gene therapy for “bubble boy” disease. The restoration of cellular activity…
After 40 years, the Alzheimer’s Association sees signs of progress against a devastating disease. Is it real?
CHICAGO — In 1979, a man named Jerome Stone, frustrated with the lack of options…
A Chinese biotech partners with GSK to boost its coronavirus vaccine development
A Chinese biotech has taken up vaccine maker GSK’s offer to share its vaccine-boosting platform…
STAT Plus: With strong data on lead drug, Kadmon and CEO Harlan Waksal plot their redemption
Months and even years after a successful bone marrow transplant, when patients in remission finally…
The coronavirus is picking up steam outside China, narrowing chances of eliminating it
There are worrying signs the coronavirus outbreak is entering a new phase, with spread outside…
STAT Plus: After 21-year journey, Esperion to test market for a cholesterol pill that is less expensive than some competitors
A new cholesterol-lowering medication manufactured by Esperion Therapeutics was approved by the Food and Drug…
Antigen-based metric could better predict which patients benefit from immunotherapy, study says
Immunotherapy has unleashed a revolution in care for some cancer patients. But most immunotherapies help…
STAT Plus: Pharmalittle: Canada may change new rules for drug prices; Trump frustrated over drug pricing
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Human reproductive cloning: The curious incident of the dog in the night-time
Gregory: Is there any other point to which you would wish to draw my attention?Holmes:…
Opinion: Should ‘broken’ genes be fixed? My daughter changed the way I think about that question
I’m a doctor. I strive to fix things that are broken. Hearts, mostly. But my…
Once widely criticized, the Wuhan quarantine bought the world time to prepare for Covid-19
“Could cause panic.” “Will not help end the crisis.” “Could backfire.” When the Chinese government…
STAT Plus: In a cramped Kendall Square, biotech startups sublet desks and squeeze into shared labs
Before it launched in January, biotech startup EQRx wasn’t quite large enough to justify leasing…
STAT Plus: Roche confirms departure of gene therapy pioneer Kathy High
Kathy High, a gene therapy pioneer who led the development of a treatment for a…
Listen: Drug industry infighting, the human side of genetic medicine, and a big year for the microbiome
Can biopharma police itself? Who decides whether something’s a disease or a difference? And will…
Experts say confusion over coronavirus case count in China is muddying picture of spread
Infectious diseases experts are losing confidence in the accuracy of China’s count of cases of…
STAT Plus: Gilead loses another challenge to a pair of U.S. patents for an HIV prevention pill
For the second time this month, Gilead Sciences (GILD) has lost a bid to invalidate…
STAT Plus: Rising out-of-pocket costs for dementia and neuropathy drugs lower patient adherence
As out-of-pocket costs rise for medicines used to treat certain neurologic disorders — such as…
In rough U.S. flu season for kids, vaccine working OK so far
NEW YORK — It may end up being a bad flu season for kids, but…
STAT Plus: FDA names genes that may interact with specific drugs, offering clarity to genetic testing industry
The burgeoning industry built around telling patients how their genes may interact with specific drugs…
Aided by machine learning, scientists find a novel antibiotic able to kill superbugs in mice
For decades, discovering novel antibiotics meant digging through the same patch of dirt. Biologists spent…
STAT Plus: Pharmalittle: Need cheap insulin? Try Craigslist; Trump warned about monopolies on coronavirus treatments
Rise and shine, everyone, another busy day is on the way. We can tell because…
A startup aims to reimagine the executive physical — with Silicon Valley flourish and a $3,500 price tag
SAN FRANCISCO — The three-martini lunch may be on the decline, but many big companies…
STAT Plus: Lawmakers to Trump: Don’t give ‘monopolies’ to companies that develop coronavirus treatments with taxpayer funds
Nearly four dozen lawmakers asked the White House to ensure any treatment for the fast-moving…
Opinion: Approaches to complex care innovation are ‘naïve and insufficient.’ We need systems and design thinking
I was a second-year medical school student when I encountered my first patient with GRID…
Opinion: Digital therapeutics vs. digital care: defining the landscape
The conversations I had at this year’s J.P. Morgan Healthcare Conference were a microcosm of…
Scientists turn organs transparent — and use a new technique to capture 3D pictures of what’s inside
Scientists in Germany have turned human organs transparent and captured pictures of the complex cellular…
How the psychology of a $4.99 price tag might influence who undergoes heart surgery
Health economists aren’t generally known for their humor. There’s something about Medicaid that’s just deeply…
How many? The coronavirus is prompting a burst of clinical trials in search of a treatment
The coronavirus sweeping across China has triggered a burst of research activity aimed at finding…
Claws of health? Lobster blood could play role in new drugs
PORTLAND, Maine — Maine lobsters have long delighted tourists as the state’s most beloved seafood….
STAT Plus: Biotech founder who said his painkiller would replace opioids sentenced to 7 years in prison
The founder of a biotech who said his company had developed a painkiller that would…
California governor to address homelessness, mental health
SACRAMENTO, Calif. — California’s governor is expected to call for better mental health care to…
STAT Plus: European Union proposes independent audits for high-risk AI systems
A version of this story appeared in STAT’s Health Tech newsletter. Click here to subscribe. European regulators…
STAT Plus: Pharma execs criticize a drug maker over pricing and claim orphan drug law is being misused
Several prominent biotech and pharmaceutical executives are openly criticizing a huge price hike for a…
STAT Plus: Pharmalittle: Prices for active ingredients rise in China due to coronavirus; Grassley presses his drug pricing bill
Top of the morning, and a fine one it is. Warm and sunny skies are…
Opinion: We need to take steps toward building a consensus definition of biological aging
I’ve been committed to understanding the biology of aging since I was a teenager, and…
Opinion: Why we need mandatory labeling of GMO products
The conversation around genetic engineering and food is undermined by a lack of information that…
STAT Plus: Sen. Chuck Grassley takes your questions on drug prices, insulin, and innovation
WASHINGTON — Sen. Chuck Grassley has a clear position on this Congress’s priority list. “You…
STAT Plus: Consumer groups and unions try again to block the AbbVie and Allergan merger
A coalition of consumer groups and unions hopes to convince the Federal Trade Commission to…
Watch: What patients and their families learned from facing a deadly disease
Dr. David Fajgenbaum went from being a healthy third-year medical student to suddenly suffering multi-organ-system…
.jpg)
Watch: VCs have to predict the future. Here’s what three of them expect next in biotech
Biotech venture capitalists make their money by seeing the future better than most of us,…
Sanofi announces it will work with HHS to develop coronavirus vaccine
The drug maker Sanofi Pasteur is entering the race to develop a vaccine to protect…
STAT Plus: Pharmalittle: Coronavirus clinical trials are going slower than hoped; opioid lawsuit payouts may be less than expected
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Welcome to the STAT China newsletter
A version of this story first appeared in the weekly STAT China newsletter. To receive…
STAT Plus: ‘Pharma doesn’t like fish oil’: Wall Street funds sold Amarin after big win with heart drug
Wall Street fund managers lightened their stock positions in Amarin (AMRN) during the fourth quarter…
Opinion: Without oversight, electronic prescribing can harm patients
The use of electronic health record systems in doctors’ offices and hospitals has hit a…
Opinion: FDA calls states’ bluffs on drug importation
For decades, critics of the U.S. drug pricing system have advocated importing drugs from Canada…
There’s no one-size-fits-all for healthy physician bodies. Why don’t ads for trendy medical scrubs reflect that?
Last year I treated a young patient struggling with body image issues. This child’s parents…
STAT Plus: Microbiome-based drug makers are hoping new late-stage data will pull the field out of the shadows
The microbiome industry is on the cusp of a turning point. Seres Therapeutics, one of…
Opinion: For African women at risk of HIV, a woke world is still sound asleep
The arrival in 2012 of a daily pill to prevent HIV infection was widely hailed…